Ligand Pharmaceuticals, Inc. (LGND)
183.98
-2.34
(-1.26%)
USD |
NASDAQ |
Feb 20, 16:00
183.59
-0.39
(-0.21%)
Pre-Market: 20:00
Ligand Pharmaceuticals Market Cap : 3.621B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 303.45B |
| ADMA Biologics, Inc. | 3.832B |
| Johnson & Johnson | 584.38B |
| Elanco Animal Health, Inc. | 12.41B |
| Ionis Pharmaceuticals, Inc. | 13.47B |
Market Cap Related Metrics
| PE Ratio | 88.55 |
| PS Ratio | 14.41 |
| Price to Book Value | 3.811 |
| Price to Free Cash Flow | 177.23 |
| Price | 183.98 |
| Earnings Yield | 1.13% |
| Operating PE Ratio | 125.52 |
| Normalized PE Ratio | 815.15 |